Mark Warner Talks to the Financial Post About Pharmaceutical Issues in the NAFTA Renegotiation

Mark Warner was quoted in the Financial Post* *about U.S. demand for Canadian extension of the “data exclusivity” period for biologic drugs in the renegotiation of the North American Free Trade Agreement (NAFTA). (September 24, 2018) Mr. Warner was Legal Director of the Ontario Ministry of Economic Development & Trade and advised Ontario in the negotiation of the Canada – EU Trade Agreement (CETA) including on drug pricing and patent appeals and on other trade and investment negotiation and dispute settlement matters including NAFTA . Mr. Warner, a Canadian and U.S. lawyer, has advised pharmaceutical companies on pricing, distribution and other competition and trade matters. Mr. Warner has also governments on trade policy and trade negotiations and previously worked on trade and competition issues as counsel in the OECD Trade Directorate.